Company Biodexa Pharmaceuticals Plc

Equities

BDRX

US59564R7089

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Quarterly revenue - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Nasdaq Other stock markets 02:00:00 15/05/2024 am IST			5-day change	1st Jan Change
1.1 ^USD	+13.58%		+10.00%	-58.96%

14/05	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	MT
10/05	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT

Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.

Number of employees: 21

USD in Million	2022	Weight	2023	Weight	Delta
Pipeline Research and Development 100.0 %	1	100.0 %	0	100.0 %	-44.99%

USD in Million	2022	Weight	2023	Weight	Delta
Belgium 100.0 %	1	100.0 %	0	100.0 %	-44.99%

Managers	Title	Age	Since
Stephen Stamp CEO	Chief Executive Officer	62	09/19/09
Dan Palmer CTO	Chief Tech/Sci/R&D Officer	-	-
Dmitry Zamoryakhin CTO	Chief Tech/Sci/R&D Officer	44	11/21/11
Steve Ellul PRN	Corporate Officer/Principal	-	01/22/01
Fiona Sharp AUD	Comptroller/Controller/Auditor	-	-

Members of the board	Title	Age	Since
Stephen Parker CHM	Chairman	65	20/22/20
Sijmen de Vries BRD	Director/Board Member	65	29/14/29
Stephen Stamp CEO	Chief Executive Officer	62	09/19/09
Simon Turton BRD	Director/Board Member	56	08/14/08
Ann Merchant BRD	Director/Board Member	59	31/12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	400	2,973,944,305	2,619,516 ( 0.0881 %)	0	0.0881 %

Name	Equities	%	Valuation
Mercer Street Global Opportunity Fund LLC 64.64 %	62,496,800	64.64 %	625 $
Michael Bigger 4.608 %	4,455,260	4.608 %	45 $
L1 Global Manager Pty Ltd. 0.5603 %	541,700	0.5603 %	5 $
Woodford Investment Management Ltd. 0.2012 %	194,564	0.2012 %	2 $
Ionic Ventures LLC 0.1402 %	135,532	0.1402 %	1 $
Stephen Stamp 0.0271 %	26,188	0.0271 %	0 $
Simon Turton 0.002861 %	2,766	0.002861 %	0 $
Sijmen de Vries 0.001367 %	1,322	0.001367 %	0 $
Octopus Investments Ltd. 0.000843 %	815	0.000843 %	0 $
Canaccord Genuity Asset Management Ltd. 0.000279 %	270	0.000279 %	0 $

Name	Equities	%	Valuation
Boothbay Fund Management LLC 17.01 %	44,593	17.01 %	32 330 $
Armistice Capital LLC 9.516 %	24,951	9.516 %	18 089 $
GAMMA Investing LLC 4.234 %	11,101	4.234 %	8 048 $
Bank of America, NA (Charlotte, North Carolina) 1.997 %	5,236	1.997 %	3 796 $
Cavalry Fund I Management LLC 1.056 %	2,768	1.056 %	2 007 $
UBS Securities LLC 0.9298 %	2,438	0.9298 %	1 768 $
RhumbLine Advisers LP 0.1899 %	498	0.1899 %	361 $
Morgan Stanley Capital Services LLC 0.006102 %	16	0.006102 %	12 $
Heights Capital Management, Inc. 0.000000 %	0	0.000000 %	- $

Biodexa Pharmaceuticals Plc

1 Caspian Point Caspian Way

CF10 4DQ, Cardiff

+44 29 2048 0180

http://www.midatechpharma.com

address Biodexa Pharmaceuticals Plc(BDRX)

Name	Category and Sector
Midatech Pharma España SL Midatech Pharma España SL Pharmaceuticals: MajorHealth Technology Part of Biodexa Pharmaceuticals Plc, Midatech Pharma España SL is a pharmaceutical company located in Spain. The Spanish company operates in the field of oncology and other areas.	Pharmaceuticals: Major

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.8742 GBP

Average target price

6.337 GBP

Spread / Average Target

+624.87%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BIODEXA PHARMACEUTICALS PLC	-58.96%	4.82M
VERTEX PHARMACEUTICALS INCORPORATED	+5.33%	111B
REGENERON PHARMACEUTICALS, INC.	+12.11%	106B
BIONTECH SE	-12.56%	22.24B
ARGENX SE	-3.20%	21.25B
GENMAB A/S	-5.66%	18.97B
WUXI APPTEC CO., LTD.	-35.21%	18.52B
BEIGENE, LTD.	-10.86%	16.81B
SAREPTA THERAPEUTICS, INC.	+37.57%	12.54B
LEGEND BIOTECH CORPORATION	-26.24%	8.09B

Bio Therapeutic Drugs